The Fisher’s exact test analysis revealed a higher GTL2/DLK1 ratio in ARMS patients as compared to ERMS; this finding is consistent with LOI at the DLK1-GTL2 locus. This evidence concerns the gene MEG3 and embryonal rhabdomyosarcoma.